Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

New metronomic approach to neuroblastoma

Betablockers repurposed to treat neuroblastoma

Diabetes drug, metformin, repurposed for use against several cancers including breast

Advances in multiple myeloma: Expert panel discussion

Industry view of targeted therapy combinations in oncology

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

Networking and collaborating across borders in sub-Saharan Africa

Genomic complexity of metastatic disease and the conundrum of combinations

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care